Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease

Program Overview

The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors underscore the importance of specialty referral and shared decision making in the successful management of NTM-LD, as Dr. Anne O’Donnell and her patient, Brinkley, exemplify.

Credit Expired

Target Audience

The target audience for this activity is US-based pulmonologist and infectious disease specialists.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the current epidemiologic trends and burden posed by nontuberculous mycobacteria lung disease (NTM-LD) and its treatment
  • Institute best practices for NTM-LD management with available treatment options, including proactive monitoring for adverse events and adherence to existing and new treatments
  • Effectively incorporate shared decision making into management of patients with NTM-LD

Activity Faculty


Anne E. O'Donnell, MD

Professor, Medicine
Nehemiah and Naomi Cohen Chair in Pulmonary Disease Research
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
Georgetown University Hospital
Washington, DC


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources